Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

1. Johnson P N, Ropp D L, Ranallo C, Chaaban H, Garcia-Contreras L, Neely S, Miller J L. Inhaled Tobramycin Usage in Critically Ill Pediatric Patients Without Cystic Fibrosis: A Pediatric Pharmacy-Association, Practice-Based Research Network Survey Study. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 332-339

2. Johnson P N, Miller J L, Makoni M. Response: Commentary: Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Frontiers in pediatrics. 2025; 13 : 1571691

3. Chang E, Parman A, Johnson P N, Stephens K, Neely S, Dasari N, Kassa N, Miller J L. Correspondence on “Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit”. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 298-301

4. Chang E, Harkin M, Miller J L, Walsh C, Neely S, Johnson P N. Evaluating the Efficacy and Safety of Erythromycin for the Treatment of Gastroparesis in Infants and Children. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 70-77

5. Johnson P N, Miller J L. Peer Review as a Professional Obligation: Steps and Tips to Becoming a High-Quality Reviewer. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 570-577

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

11. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.


12. Pediatric Pharmacy Association. Fellow of Pediatric Pharmacy Association. Date: 2018.


13. Pediatric Pharmacy Advocacy Group. Outstanding Original Research Award. Date: 2018.


14. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2018.


15. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Department of Clinical and Administrative Sciences Teacher of the Year Award. Date: 2016.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More